Treatment of Bacterial Vaginosis With Oral Tinidazole
Phase 3
Completed
- Conditions
- Bacterial Vaginosis
- Registration Number
- NCT00229216
- Lead Sponsor
- Mission Pharmacal
- Brief Summary
The purpose of this study is to confirm the safety and efficacy of oral tinidazole for the treatment of bacterial vaginosis.
- Detailed Description
Tinidazole is a second-generation nitroimidazole i.e. an updated form of the standard drug used to treat bacterial vaginosis (metronidazole). Two dosing regimens are being compared to placebo to treat bacterial vaginosis, one of the most common vaginal infections.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 200
Inclusion Criteria
Clinical and microbiological diagnosis of bacterial vaginosis -
Exclusion Criteria
Other sexually transmitted disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Safety Therapeutic efficacy
- Secondary Outcome Measures
Name Time Method Clinical efficacy Microbiological efficacy
Trial Locations
- Locations (1)
Duke University School of Medicine
🇺🇸Durham, North Carolina, United States
Duke University School of Medicine🇺🇸Durham, North Carolina, United States